Mycophenolate mofetil prevents lethal acute liver failure in mice induced by bacille Calmette-Guérin and lipopolysaccharide

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 4, 2008, Pages 611-618

  Yang, Yong Feng ^a   Tan, De Ming ^b   Xie, Yu Tao ^b   Zhao, Wei ^a   Hou, Zhou Hua ^b   Zhong, Yan Dan ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Liver failure; Mice; Mycophenolate mofetil; Prevention

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; LIVER; LIVER FAILURE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; SURVIVAL RATE;

EID: 41849130628     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05169.x     Document Type: Article

References (36)

1. Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl. 2005 11 : 594 605.
2. Han DW. Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J. Gastroenterol. 2002 8 : 961 5.
3. Kitchin JE, Pomeranz MK, Pak G, Washenik K, Shupack JL. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses. J. Am. Acad. Dermatol. 1997 37 : 445 9.
4. Uchida K, Sakaida I, Hironaka K, Kayano K, Okita K. Preventive effect of FK 506 (tacrolimus hydrate) on experimentally induced acute liver injury in rats. Dig. Dis. Sci. 2000 45 : 1996 2001.
5. Iwaki T, Sugimura M, Nishihira J, Matsuura T, Kobayashi T, Kanayama N. Recombinant adenovirus vector bearing antisense macrophage migration inhibitory factor cDNA prevents acute lipopolysaccharide-induced liver failure in mice. Lab. Invest. 2003 83 : 561 70.
6. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987 162 : 156 9.
7. Yoneyama H, Harada A, Imai T et al. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J. Clin. Invest. 1998 102 : 1933 41.
8. Nagaki M, Tanaka M, Sugiyama A, Ohnishi H, Moriwaki H. Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alpha and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice. J. Hepatol. 1999 31 : 815 24.
9. Yu CL, Sun KH, Tsai CY, Hsieh SC, Yu HS. Anti-dsDNA antibody up-regulates interleukin 6, but not cyclo-oxygenase, gene expression in glomerular mesangial cells: a marker of immune-mediated renal damage? Inflamm. Res. 2001 50 : 12 18.
10. Kobayashi S, Nishihira J, Watanabe S, Todo S. Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with bacille Calmette-Guerin and lipopolysaccharide. Hepatology 1999 29 : 1752 9.
11. Wagner U, Burkhardt E, Failing K. Evaluation of canine lymphocyte proliferation: comparison of three different colorimetric methods with the 3H-thymidine incorporation assay. Vet. Immunol. Immunopathol. 1999 70 : 151 9.
12. Huang WH, Yan Y, Li J, De Boer B, House AK, Bishop GA. A short course of mycophenolate immunosuppression inhibits rejection, but not tolerance, of rat liver allografts in association with inhibition of interleukin-4 and alloantibody responses. Transplantation 2003 76 : 1159 65.
13. Durez P, Appelboom T, Pira C, Stordeur P, Vray B, Goldman M. Antiinflammatory properties of mycophenolate mofetil in murine endotoxemia: inhibition of TNF-alpha and upregulation of IL-10 release. Int. J. Immunopharmacol. 1999 21 : 581 7.
14. Izeradjene K, Revillard JP. Apoptosis of superantigen-activated T cells induced by mycophenolate mofetil treatment. Transplantation 2001 71 : 118 25.
15. Weimer R, Mytilineos J, Feustel A et al. Mycophenolate mofetil-based immunosuppression and cytokine genotypes: effects on monokine secretion and antigen presentation in long-term renal transplant recipients. Transplantation 2003 75 : 2090 9.
16. Wang GS, Liu GT. Influences of Kupffer cell stimulation and suppression on immunological liver injury in mice. Zhongguo Yao Li Xue Bao 1997 18 : 173 6.
17. Tokushige K, Yamaguchi N, Ikeda I, Hashimoto E, Yamauchi K, Hayashi N. Significance of soluble TNF receptor-I in acute-type fulminant hepatitis. Am. J. Gastroenterol. 2000 95 : 2040 6.
18. Tsuji H, Harada A, Mukaida N et al. Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis. Infect. Immun. 1997 65 : 1892 8.
19. Tsutsui H, Matsui K, Kawada N et al. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J. Immunol. 1997 159 : 3961 7.
20. Liu P, Ohnishi H, Moriwaki H, Muto Y. Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive liver cell necrosis/fatal hepatitis in mice. Gastroenterol. Jpn. 1990 25 : 339 42.
21. Fujioka N, Mukaida N, Harada A et al. Preparation of specific antibodies against murine IL-1ra and the establishment of IL-1ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J. Leukoc. Biol. 1995 58 : 90 8.
22. Matsui K, Yoshimoto T, Tsutsui H et al. Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J. Immunol. 1997 159 : 97 106.
23. Okamura H, Tsutsi H, Komatsu T et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995 378 : 88 91.
24. Nagakawa J, Hishinuma I, Hirota K et al. Involvement of tumor necrosis factor-alpha in the pathogenesis of activated macrophage-mediated hepatitis in mice. Gastroenterology 1990 99 : 758 65.
25. Nadler EP, Dickinson EC, Beer-Stolz D et al. Scavenging nitric oxide reduces hepatocellular injury after endotoxin challenge. Am. J. Physiol. Gastrointest. Liver Physiol. 2001 281 : G173 81.
26. Tulek N, Saglam SK, Saglam M, Turkyilmaz R, Yildiz M. Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection. Hepatogastroenterology 2000 47 : 828 31.
27. Cressman DE, Greenbaum LE, DeAngelis RA et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996 274 : 1379 83.
28. Streetz KL, Tacke F, Leifeld L et al. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases. Hepatology 2003 38 : 218 29.
29. Masubuchi Y, Bourdi M, Reilly TP, Graf ML, George JW, Pohl LR. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem. Biophys. Res. Commun. 2003 304 : 207 12.
30. Hecht N, Pappo O, Shouval D, Rose-John S, Galun E, Axelrod JH. Hyper-IL-6 gene therapy reverses fulminant hepatic failure. Mol. Ther. 2001 3 : 683 7.
31. Galun E, Zeira E, Pappo O, Peters M, Rose-John S. Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury. FASEB J. 2000 14 : 1979 87.
32. Klein C, Wustefeld T, Heinrich PC, Streetz KL, Manns MP, Trautwein C. ME3738 protects from concanavalin A-induced liver failure via an IL-6-dependent mechanism. Eur. J. Immunol. 2003 33 : 2251 61.
33. Zimmers TA, McKillop IH, Pierce RH, Yoo JY, Koniaris LG. Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology 2003 38 : 326 34.
34. Taub R. Hepatoprotection via the IL-6/Stat3 pathway. J. Clin. Invest. 2003 112 : 978 80.
35. Haga S, Terui K, Zhang HQ et al. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J. Clin. Invest. 2003 112 : 989 98.
36. Saad B, Frei K, Scholl FA, Fontana A, Maier P. Hepatocyte-derived interleukin-6 and tumor-necrosis factor alpha mediate the lipopolysaccharide- induced acute-phase response and nitric oxide release by cultured rat hepatocytes. Eur. J. Biochem. 1995 229 : 349 55.